<DOC>
	<DOCNO>NCT01768312</DOCNO>
	<brief_summary>The purpose clinical Study Tisporin Eye Drops 0.05 % ( Cyclosporine ophthalmic solution ) group Restasis Eye Drops 0.05 % ( Cyclosporine ophthalmic suspension ) group 12 week treatment , treatment group comparison evaluation efficacy safety Moderate Severe Dry Eye Disease . - Corneal stain test , Ocular surface disease index ( OSDI ) , Tear break time ( TBUT ) , Non-anesthetic Schirmer test</brief_summary>
	<brief_title>Study Cyclosporine Ophthalmic Soution Group Cyclosporine Ophthalmic Suspension Group</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>[ Patients moderatetosevere ocular dry eye ] 1 . The sum corneal fluorescein stain score 5 high ( NEI Scale ) 2 . Nonanesthetic Schirmer test value ≤ 5mm/5min patient least one eye score ( Nonanesthetic Schirmer test value = 0/5min , nasal stimulation eye , Schirmer test value ≥ 3mm/5min ) 3 . Screening eye , correct visual acuity 0.2 4 . Despite conventional treatment , symptom dry eye sign ( Artificial tear eye drop , sympathetic nervous system stimulant agent , parasympathetic nerve stimulant , etc . ) 5 . Negative urine pregnancy test screen woman childbearing age 6 . Medically reliable method contraception case woman childbearing age menopause ( 1 year last menstrual period woman ) Sterilization ( eg , bilateral oophorectomy , hysterectomy ) woman childbearing age effective contraception participate clinical trial may determine pregnant examine whether voice , maintain entire clinical trial period shall . 7 . Written consent voluntarily participate clinical trial 1 ) Screening visit previous 3 month ( 12 week ) participate clinical trial cyclosporine eye drop , use cyclosporine ophthalmic solution . 2 ) The patient systemic ocular disorder affect test result ( ocular surgery , trauma , disease ) 1 . Abnormal eyelid function : Disoders eyelids eyelash 2 . Ocular allergy currently treatment allergic disease eye ( topical ocular mast cell stabilizer , antihistamine use , etc . ) 3 . Cicatricial keratoconjunctivitis cause herpetic keratopathy , conjunctival scarring ( alkali damage , StevenJohnson syndrome , cicatricial pemphigoid ) , pterygium , pinguecula , lack congenital lacrimal , neurogenic keratitis , keratoconus , corneal transplantation 3 ) current recent patient use dry eye syndrome medication ( topical systemic ) may affect status 4 ) The use clinical trial drug hypersensitivity reaction patient 5 ) patient contact lens 6 ) If use plan use punctual plug within 4 week 7 ) Lacrimal punctual occlusion surgery patient 8 ) Ocular surgery within 3 month ( 12 week ) 9 ) Pregnant woman , lactate , plan become pregnant 10 ) The end lacrimal gland disease ( Nasal stimulation Schirmer test value &lt; 3mm/5min ) 11 ) History malignancy 12 ) If receive systemic steroid immunosuppressive treatment 15 ) In patient severe renal failure ( serum creatinine 2.0 time upper limit normal ) 16 ) In patient severe liver dysfunction ( ALT AST 2.0 time upper limit normal ) 17 ) Alcohol drug abuse 18 ) Pregnant woman , lactate woman 19 ) Participating Clinical Trial patient participate clinical trial within three month 20 ) Patients judge coexist disease could interfere completion treatment safety clinical trial . Patients researcher determine inadequately</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>